Some of the identified pathways have been reported to be closely related with lung cancer in a previous study (44)—for example, the defective HLA class I antigen processing and presentation machinery components played a role in the acquired resistance to PD-1 or PD-L1 antagonistic antibodies in immune checkpoint inhibitor-resistant lung cancer samples (45). The gene discussed is CD274; the disease is lung carcinoma.